scholarly journals Impact of Big Data Analytics on People’s Health: Overview of Systematic Reviews and Recommendations for Future Studies

10.2196/27275 ◽  
2021 ◽  
Vol 23 (4) ◽  
pp. e27275
Author(s):  
Israel Júnior Borges do Nascimento ◽  
Milena Soriano Marcolino ◽  
Hebatullah Mohamed Abdulazeem ◽  
Ishanka Weerasekara ◽  
Natasha Azzopardi-Muscat ◽  
...  

Background Although the potential of big data analytics for health care is well recognized, evidence is lacking on its effects on public health. Objective The aim of this study was to assess the impact of the use of big data analytics on people’s health based on the health indicators and core priorities in the World Health Organization (WHO) General Programme of Work 2019/2023 and the European Programme of Work (EPW), approved and adopted by its Member States, in addition to SARS-CoV-2–related studies. Furthermore, we sought to identify the most relevant challenges and opportunities of these tools with respect to people’s health. Methods Six databases (MEDLINE, Embase, Cochrane Database of Systematic Reviews via Cochrane Library, Web of Science, Scopus, and Epistemonikos) were searched from the inception date to September 21, 2020. Systematic reviews assessing the effects of big data analytics on health indicators were included. Two authors independently performed screening, selection, data extraction, and quality assessment using the AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews 2) checklist. Results The literature search initially yielded 185 records, 35 of which met the inclusion criteria, involving more than 5,000,000 patients. Most of the included studies used patient data collected from electronic health records, hospital information systems, private patient databases, and imaging datasets, and involved the use of big data analytics for noncommunicable diseases. “Probability of dying from any of cardiovascular, cancer, diabetes or chronic renal disease” and “suicide mortality rate” were the most commonly assessed health indicators and core priorities within the WHO General Programme of Work 2019/2023 and the EPW 2020/2025. Big data analytics have shown moderate to high accuracy for the diagnosis and prediction of complications of diabetes mellitus as well as for the diagnosis and classification of mental disorders; prediction of suicide attempts and behaviors; and the diagnosis, treatment, and prediction of important clinical outcomes of several chronic diseases. Confidence in the results was rated as “critically low” for 25 reviews, as “low” for 7 reviews, and as “moderate” for 3 reviews. The most frequently identified challenges were establishment of a well-designed and structured data source, and a secure, transparent, and standardized database for patient data. Conclusions Although the overall quality of included studies was limited, big data analytics has shown moderate to high accuracy for the diagnosis of certain diseases, improvement in managing chronic diseases, and support for prompt and real-time analyses of large sets of varied input data to diagnose and predict disease outcomes. Trial Registration International Prospective Register of Systematic Reviews (PROSPERO) CRD42020214048; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=214048

2021 ◽  
Author(s):  
Israel Júnior Borges do Nascimento ◽  
Milena Soriano Marcolino ◽  
Hebatullah Mohamed Abdulazeem ◽  
Ishanka Weerasekara ◽  
Natasha Azzopardi-Muscat ◽  
...  

BACKGROUND Although the potential of big data analytics for health care is well recognized, evidence is lacking on its effects on public health. OBJECTIVE The aim of this study was to assess the impact of the use of big data analytics on people’s health based on the health indicators and core priorities in the World Health Organization (WHO) General Programme of Work 2019/2023 and the European Programme of Work (EPW), approved and adopted by its Member States, in addition to SARS-CoV-2–related studies. Furthermore, we sought to identify the most relevant challenges and opportunities of these tools with respect to people’s health. METHODS Six databases (MEDLINE, Embase, Cochrane Database of Systematic Reviews via Cochrane Library, Web of Science, Scopus, and Epistemonikos) were searched from the inception date to September 21, 2020. Systematic reviews assessing the effects of big data analytics on health indicators were included. Two authors independently performed screening, selection, data extraction, and quality assessment using the AMSTAR-2 (A Measurement Tool to Assess Systematic Reviews 2) checklist. RESULTS The literature search initially yielded 185 records, 35 of which met the inclusion criteria, involving more than 5,000,000 patients. Most of the included studies used patient data collected from electronic health records, hospital information systems, private patient databases, and imaging datasets, and involved the use of big data analytics for noncommunicable diseases. “Probability of dying from any of cardiovascular, cancer, diabetes or chronic renal disease” and “suicide mortality rate” were the most commonly assessed health indicators and core priorities within the WHO General Programme of Work 2019/2023 and the EPW 2020/2025. Big data analytics have shown moderate to high accuracy for the diagnosis and prediction of complications of diabetes mellitus as well as for the diagnosis and classification of mental disorders; prediction of suicide attempts and behaviors; and the diagnosis, treatment, and prediction of important clinical outcomes of several chronic diseases. Confidence in the results was rated as “critically low” for 25 reviews, as “low” for 7 reviews, and as “moderate” for 3 reviews. The most frequently identified challenges were establishment of a well-designed and structured data source, and a secure, transparent, and standardized database for patient data. CONCLUSIONS Although the overall quality of included studies was limited, big data analytics has shown moderate to high accuracy for the diagnosis of certain diseases, improvement in managing chronic diseases, and support for prompt and real-time analyses of large sets of varied input data to diagnose and predict disease outcomes. CLINICALTRIAL International Prospective Register of Systematic Reviews (PROSPERO) CRD42020214048; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=214048


2017 ◽  
Vol 2017 ◽  
pp. 1-16 ◽  
Author(s):  
Dillon Chrimes ◽  
Hamid Zamani

Big data analytics (BDA) is important to reduce healthcare costs. However, there are many challenges of data aggregation, maintenance, integration, translation, analysis, and security/privacy. The study objective to establish an interactive BDA platform with simulated patient data using open-source software technologies was achieved by construction of a platform framework with Hadoop Distributed File System (HDFS) using HBase (key-value NoSQL database). Distributed data structures were generated from benchmarked hospital-specific metadata of nine billion patient records. At optimized iteration, HDFS ingestion of HFiles to HBase store files revealed sustained availability over hundreds of iterations; however, to complete MapReduce to HBase required a week (for 10 TB) and a month for three billion (30 TB) indexed patient records, respectively. Found inconsistencies of MapReduce limited the capacity to generate and replicate data efficiently. Apache Spark and Drill showed high performance with high usability for technical support but poor usability for clinical services. Hospital system based on patient-centric data was challenging in using HBase, whereby not all data profiles were fully integrated with the complex patient-to-hospital relationships. However, we recommend using HBase to achieve secured patient data while querying entire hospital volumes in a simplified clinical event model across clinical services.


2019 ◽  
Vol 54 (5) ◽  
pp. 20
Author(s):  
Dheeraj Kumar Pradhan

2020 ◽  
Vol 49 (5) ◽  
pp. 11-17
Author(s):  
Thomas Wrona ◽  
Pauline Reinecke

Big Data & Analytics (BDA) ist zu einer kaum hinterfragten Institution für Effizienz und Wettbewerbsvorteil von Unternehmen geworden. Zu viele prominente Beispiele, wie der Erfolg von Google oder Amazon, scheinen die Bedeutung zu bestätigen, die Daten und Algorithmen zur Erlangung von langfristigen Wettbewerbsvorteilen zukommt. Sowohl die Praxis als auch die Wissenschaft scheinen geradezu euphorisch auf den „Datenzug“ aufzuspringen. Wenn Risiken thematisiert werden, dann handelt es sich meist um ethische Fragen. Dabei wird häufig übersehen, dass die diskutierten Vorteile sich primär aus einer operativen Effizienzperspektive ergeben. Strategische Wirkungen werden allenfalls in Bezug auf Geschäftsmodellinnovationen diskutiert, deren tatsächlicher Innovationsgrad noch zu beurteilen ist. Im Folgenden soll gezeigt werden, dass durch BDA zwar Wettbewerbsvorteile erzeugt werden können, dass aber hiermit auch große strategische Risiken verbunden sind, die derzeit kaum beachtet werden.


2019 ◽  
Vol 7 (2) ◽  
pp. 273-277
Author(s):  
Ajay Kumar Bharti ◽  
Neha Verma ◽  
Deepak Kumar Verma

2017 ◽  
Vol 49 (004) ◽  
pp. 825--830
Author(s):  
A. AHMED ◽  
R.U. AMIN ◽  
M. R. ANJUM ◽  
I. ULLAH ◽  
I. S. BAJWA

Sign in / Sign up

Export Citation Format

Share Document